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The sensititivity of thermophilic Campylobacter strains isolated from caecum of broiler chickens as well 
as caecum and colon of pigs and human stools, were tested against erythromycin. In 16 strains isolated 
in broiler chickens, resistance rate was found to be 12.50%. Three of 10 strains of Campylobacter jejuni 
and one of 6 strains of Campylobacter coli isolated from broiler chickens were resistant to 
erythromycin. In 15 strains of thermophilic Campylobacters isolated from pigs, resistance rate to 
erythromycin was 40.00%. Resistance was exhibited more often in C. coli (50.00%) as compared to C. 
jejuni (20.00%). In 24 strains isolated from humans, resistance was demonstrated at the rate of 12.50%. 
Out of 17 strains of C. jejuni isolated from humans, resistance was exhibited in 17.65% strains. None of 
7 strains of C. coli isolated from humans exhibited resistance to erythromycin. Thermophilic 
campylobacters, especially C. coli isolated from pigs were more resistant to erythromycin than strains 
isolated from humans and broiler chickens. Therefore, a great attention should be directed to the 
macrolides monitoring in swine farming in order to prevent resistance in animals and its subsequent 
spread to human.  
 
Key words: Campylobacter spp., resistance, erythromycin. 
 
 
INTRODUCTION 
 
Campylobacteriosis is the most frequent intestinal 
bacterial infection in humans, more frequent than 
salmonellosis, shigellosis, infections caused by 
enterohaemorrhagic Escherichia coli strains and 
yersiniosis. Intestinal campylobacteriosis in humans is 
the result of infection due to thermophilic Campylobacter 
spp., mostly Campylobacter jejuni and Campylobacter 
coli, resulting in 400 million bacterial intestinal infections 
around the world every year (Putnam et al., 2003; 
Zimmer et al., 2003). A very important factor in intestinal 
campylobacteriosis development is a very low infective 
doses of only 500 bacteria (Walker et al., 1986). 
Campylobacter spp.  is   a   major    cause    of    bacterial  
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enterocolitis   and    travelers'   diarrhoea  (Vlieghe et al., 
2008). 
Poultry in age of two to three weeks are 50 to 90% 
colonized by thermophilic Campylobacter spp. (Hariharan 
et al., 2009; Newel, 2002). Swines are less colonized by 
Campylobacters spp. than poultry. A similar result has 
been obtained in a study performed in Serbia (Tambur et 
al., 2008). 
Drugs which are generally used in human 
campylobacteriosis treatment are erythromycin, 
quinolones, tetracycline, ampicillin, chloramphenicol and 
gentamycin. The actual increase of resistance to 
erythromycin (drug of the therapeutic choice) in 
thermophilic Campylobacter spp. isolated from humans 
has become allarming (Bywater et al., 2004; Cardinale et 
al., 2002). Emergence of the resistant strains coincided 
with the beginning of macrolides use, for the most part 
thylosine,  in veterinary medicine, mainly in swine farming  
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Table 1. Resistance of Campylobacter isolates from broiler chickens, pigs and humans as determined by E test. 
 
Source of strains No. of strains *MIC range **MIC50 ***MIC90 Resistance (%) 
Broiler chickens 16 0.016 - >256 0.125 >256 12.50 
Pigs 15 0.016 - >256 1.5 >256 40.00 
Humans 24 0.016 - >256 0.125 >256 12.50 
 
* Minimum inhibitory concentration, ** Minimum inhibitory concentration required to inhibit the growth of 50% of organisms,***
 
Minimum inhibitory concentration required to inhibit the growth of 90% of organisms. 
 
 
 
Table 2. Results of erythromycin MIC determination by E-test for C. jejuni isolated from broiler chickens, pigs and humans 
 
Source of strains  No. of strains *MIC range **MIC50 ***MIC90 Resistance (%) 
Broiler chickens 10 0.016 - 64 0.25 2 33.33 
Pigs 5 0.016 - 64 0.016 64 20.00 
Humans 17 0.023 - >256 0.25 >256 17.65 
 
* Minimum inhibitory concentration,** Minimum inhibitory concentration required to inhibit the growth of 50% of organisms, ***
 
Minimum inhibitory concentration required to inhibit the growth of 90% of organisms. 
 
 
 
(Aarestrup and Engberg, 2001; Luber et al., 2003).  
Since there was little published work on thermophilic 
Campylobacter spp. isolated from animals and humans 
available in Serbia, it is our objective to determine the 
sensitivity to erythromycin of thermophilic Campylobacter 
spp. isolated from humans and animals. 
 
 
MATERIALS AND METHODS 
 
Strains of thermophilic Campylobacter spp. were obtained from 
caecum of broiler chickens as well as caecum and colon of pigs 
and human stools. Four hundred and four animal specimens were 
investigated: 24 obtained by scrapping of broiler chickens caecum 
surfaces, and 31 obtained by scrapping of pigs caecum and colon 
surfaces. The following procedures were used for the isolation of 
thermophilic Campylobacter in animals. 
Immediately after collection, samples were, in aim to obtain 
individual colonies, diluted and inoculated on Karmali and Skirrow 
agar. Inoculated plates were placed in pots for anaerobes and then, 
by Campy Pak, BBL bags, microaerophilic conditions were created. 
In the laboratory, transported pots were transferred in thermostats 
and incubated in microaerophilic conditions at 42°C for 48 h. 
After incubation, suspicious colonies were picked and dyed with 
2% carbol fuchsin for the morphology visualization of 
Campylobacter (“gull wings”, S or spiral shaped bacteria). To obtain 
pure culture of thermophilic Campylobacter spp. individual colonies 
were subcultured on Karmali or blood agar plates. 
For further characterization, isolated bacteria were kept in brain 
heart infusion (BHI) broth with 30% glycerol at temperature of -70°C 
(Chan et al., 2001). A total of 24 human strains were isolated at the 
Institute for Public Health in Niš, Serbia. Strains from human feces 
were isolated on Columbia agar base supplemented with 5% sheep 
blood and antibiotics (cefoperazone 1.5 g/L, colistin 106 U, 
vancomycin 1 g/L, amphotericin B 0.2 g/L), (bioMérieux, Marcy 
l’Etoile, France), followed by incubation under microaerobic 
conditions (bioMérieux, Marcy l’Etoile, France), at 42°C for 48 h. 
Identification at the genus level was made using colony 
morphology, Gram staining (“gull wings”, S or spiral shaped 
bacteria), oxidase and catalase tests. For identification and 
erythromycin susceptibility testing, strains were sent to the Military 
Medical Academy, Belgrade, Serbia in BHI broth with  30%  glycerol  
at +4°C (Chan et al., 2001).  
Isolated bacteria were identified by catalase test, oxidase test, 
hippurate hydrolysis test, indoxyl acetate hydrolysis, fast H2S test, 
susceptibility to cephalotine and nalidixic acid (Aarestrup et al., 
1997; Jain et al., 2005). Final identification of Campylobacter spp. 
was performed by automatic identification system API Campy 
produced by Bio Mérieux, (France). Assessment of thermophilic C. 
jejuni and C. coli susceptibility to erythromycin was performed by E-
test (AB BIODISK, Solna, Sweden) where breakpoints between 
0.5 g/ml and 8 g/ml were interpreted according to the 
recommendation of manufacturer.  
 
 
RESULTS 
 
In total, fifty-five Campylobacter spp. strains were 
studied: 10 C. jejuni and 6 C. coli strains from broiler 
chickens, 5 C. jejuni and 10 C. coli from pigs as well as 
17 C. jejuni and 7 C. coli strains from humans. Six out of 
15 Campylobacter strains isolated from pigs showed the 
highest level of resistance against erythromycin. For 
isolates from broiler chickens and humans, resistance to 
erythromycin was 12.50% (Table 1). 
Three of 17 C. jejuni strains isolated from humans were 
resistant to erythromycin. Three of 10 C. jejuni strains 
isolated from broiler chickens and 1 of 5 strains isolated 
from pigs were resistant to erythromycin (Table 2). None 
of 7 C. coli strains isolated from humans were resistant to 
erythromycin. One of 6 C. coli strains isolated from broiler 
chickens and 5 of 10 C. coli strains isolated from pigs 
were resistant to erythromycin (Table 3).  
 
 
DISCUSSION 
 
Based on the MIC values obtained by E-test, resistance 
to erythromycin of Campylobacter spp. isolated from 
humans was 12.5%. Our results are in accordance to the 
results of others (Burch, 2002; Ge et al., 2002; Pezzotti et  
344         Afr. J. Pharm. Pharmacol. 
 
 
 
Table 3. Results of erythromycin MIC determination by E-test for C. coli isolated from broiler chickens, pigs and humans. 
 
Source of strains No. of strains *MIC range **MIC50 ***MIC90 Resistance (%) 
Broiler chickens 6 0.016 - >256 0.50 >256 16.67 
Pigs 10 0.016 - >256 48.00 >256 50.00 
Humans 7 0.016 – 0.50 0.125 0.50 0.00 
 
*Minimum inhibitory concentration,** Minimum inhibitory concentration required to inhibit the growth of 50% of organisms,***
 
Minimum inhibitory concentration required to inhibit the growth of 90% of organisms. 
 
 
 
al., 2003; Sáenz et al., 2000). High percentage (24.1%) 
of thermophilic Campylobacter strains resistant to 
erythromycin isolated from humans in developed 
countries is a surprising fact, having in mind a strict 
control of antibiotic use in human and veterinary medicine 
in these countries. 
In some countries, for example Chile and Egypt, have 
not documented the resistance to erythromycin in strains 
isolated from humans (Fernández et al., 2000; Putnam et 
al., 2003). Lower level of resistance to erythromycin, 
ranging from 3.4 to 9.1% was reported by authors from 
Australia, India, USA, Brasil and Belgium (Alfredson et 
al., 2003; Aquino et al., 2002; Gupta et al., 2004; Jain et 
al., 2005; Vlieghe et al., 2008).  
There is a tendency of increase in resistance of 
Campylobacter to erythromycin. In 1998, 3% C. jejuni/coli 
resistant strains were reported in Canada, but the 
percentage rose to 12% in 2001 (Gaudreau and Michaud, 
2003). In Germany, 7.1 and 29.4% C. coli resistant to 
erythromycin were reported in 1991 and 2001, 
respectively (Luber et al., 2003). Besides, a rising trend 
of resistance to erythromycin was reported in Northern 
Ireland, from 0.6% in 1996 to 4.2% in 2000 (Moore et al., 
2001). 
In our study even 12.5% Campylobacter strains 
resistant to erythromycin were detected, in spite of the 
fact that this antibiotic has not been used in poultry. Our 
results are in accordance with results of other authors 
(Aarestrup et al., 1997; Burch, 2002; Avrain et al., 2003).  
A low level of resistance to erythromycin was registered 
in Great Britain (0 to 8%), USA (3.1%) and Czech 
Republic (6%) (Bardon et al., 2009; Bywater et al., 2004; 
Hariharan et al., 2009). Engberg et al. (2004) reported 
2% C. jejuni and 18.5% C. coli strains resistant to 
erythromycin. Data concerning such a high level of 
resistance to erythromycin in Campylobacter strains 
isolated from poultry are surprising having in mind that 
Denmark is a developed country in which the use of 
antibiotics is limited to therapeutic indications only. 
A   high   percentage   of  C. coli  strains  resistant  to 
erythromycin isolated from broiler chickens and eggs-
laying hens (35 and 50%) was registered in Japan 
(Ishihara et al., 2004), South Africa (Bester and Essack, 
2008) and USA (Han et al., 2009). Authors in Italy 
reported a high level of resistance to erythromycin, up to 
45%, in C. coli strains isolated from poultry faeces 
(Pezzotti et al., 2003). 
Macrolides are widely used in swine farming and, as a 
consequence of intensive pressure of drugs included in 
this thylosine group a rise of Campylobacter strains 
resistant to erythromycin originating from swines occured. 
In our study, 40% resistant Campylobacter strains were 
detected from pigs with a higher degree of resistance 
(50%) detected in C. coli strains. Several authors cited 
significantly higher percentage of resistant 
Campylobacter strains, while some others reported 
results in accordance to the results obtained in this 
investigation. 
A high percentage (74 and 71%) of resistant C. coli 
strains isolated from swine was reported in Denmark 
(Aarestrup et al., 1997) and Canada, respectively 
(Rosengren et al., 2009). A high percentage of resistance 
in C. coli originating from swines was reported in Spain 
(81%), and in Denmark this percentage in C. jejuni 
strains was 33%, and in C. coli strains was 74% (Burch, 
2002). The investigators in Denmark detected in swines 
35% C. jejuni and 57% C. coli resistant to erythromycin. 
Bywater et al. (2004), reported that 41.8% strains of C. 
jejuni/coli in Holand and 36.7% strains in Denmark were 
resistant to erythromycin. Resistance to erythromycin is 
detected in 39.7% C. jejuni/coli strains isolated from 
swines in USA (Gebreyes et al., 2005). Hart et al. (2004) 
reported on 75.5% strains isolated in Australia from 
swines before evisceration and 86.8% after evisceration 
resistant to erythromycin. Even 81.1% C. jejuni/coli 
strains isolated from swines in Spain were resistant to 
erythromycin (Sáenz et al., 2000). A high percentage of 
resistance to erythromycin is registered in thermophilic 
Campylobacter strains isolated from swines in France 
(55%) (Payot et al., 2004). These results are nearly 
identical to results obtained in this investigation. 
Schuppers et al. (2005) in Switzerland reported a level of 
19.2% C. jejuni/coli strains resistant to erythromycin, 
significantly lower than in data reported by authors in 
other countries. 
Continuous surveillance of resistance to erythromycin 
in thermophilic campylobacters is necessary, since 
resistance occurs in both humans and animals strains. 
The strains isolated from pigs were more often resistant 
to erythromycin than the strains isolated from human and 
broiler chickens. Therefore, a great attention should be 
directed to the macrolydes application monitoring in 
swine farming in order to prevent resistance apperance in 
animal  strains  and  its  subsequent   spread   to   human  
  
 
 
strains. 
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